Oncology

Latest News

PD-1 blockade has previously shown success in a first-line setting in ES-SCLC, and nab-paclitaxel is albumin-bound and solvent-free, which the investigators explained may minimize the toxicity associated with paclitaxel therapy. | Image credit: didesign - stock.adobe.com
Camrelizumab Plus Carboplatin, Nab-Paclitaxel Shows Efficacy in ES-SCLC

August 29th 2025

The 6-month progression-free survival rate for the combination therapy was 52.2%.

For rent sign | Image Credit: David Gales - stock.adobe.com
Housing Assistance May Help Renters With Cancer Better Withstand Medical Financial Strain

August 28th 2025

Patient with cancer undergoing chemotherapy | Image credit: RFBSIP – stock.adobe.com
Many Patients With Advanced Cancer Report Care Misaligned With Their Goals

August 25th 2025

Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap
Innovation vs Affordability: Cancer Care’s Cost Crisis and Access Gap

August 21st 2025

The investigators found that tumor mutational burden and PD-L1 expression, which have traditionally been used as indicators of immunotherapy efficacy, had little predictive value for survival in this cohort. | Image credit: Dragana Gordic - stock.adobe.com
Predictive Model Forecasts Advanced NSCLC Outcomes

August 14th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations
Continuing Medical Education
View All
August 29th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 29th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Site Logo
December 31st 2015

Can Virtual Colonoscopies Be a Reality for Population Screening?

Surabhi Dangi-Garimella, PhD
A study published in the Journal of the National Cancer Institute found that ease of preparation prior to the screening test is an important determinant of colonoscopy uptake.
Site Logo
December 31st 2015

Aspirin May Lower Breast Tissue Density, Lead to Early Detection of Cancer

Jackie Syrop
New data does not support the idea that aspirin has protective qualities and “down-the-road” benefits for breast cancer patients. It may, however, help reduce breast density and improve earlier detection of some breast cancers.
Closing Statements
December 30th 2015

Closing Statements

Are Patients Aware of Site of Care Differentials?
December 30th 2015

Are Patients Aware of Site of Care Differentials?

Disparity in Site of Care Costs and Patient Burden
December 30th 2015

Disparity in Site of Care Costs and Patient Burden

The Path to Site Neutrality
December 30th 2015

The Path to Site Neutrality

Performance-Based Contracting in Oncology
December 30th 2015

Performance-Based Contracting in Oncology

Can Indication-Based Pricing Be a Reality?
December 30th 2015

Can Indication-Based Pricing Be a Reality?

Oral Parity Laws and Patient Cost Sharing
December 30th 2015

Oral Parity Laws and Patient Cost Sharing

Drug Prices and Patient Burden in Oncology
December 30th 2015

Drug Prices and Patient Burden in Oncology

Bundled Payments in Oncology: What Do Payers Think?
December 30th 2015

Bundled Payments in Oncology: What Do Payers Think?

Implications of Bundled Payments in Oncology
December 30th 2015

Implications of Bundled Payments in Oncology

What Are the Constructs of Value-Based Care?
December 30th 2015

What Are the Constructs of Value-Based Care?

Can Academic Innovation in LDTs Be Halted?
December 30th 2015

Can Academic Innovation in LDTs Be Halted?

LDTs and the Political Wheelhouse
December 30th 2015

LDTs and the Political Wheelhouse

Justifying the Need for FDA Regulation of LDTs
December 30th 2015

Justifying the Need for FDA Regulation of LDTs

Payer and Consumer Response to FDA Regulation of LDTs
December 30th 2015

Payer and Consumer Response to FDA Regulation of LDTs

What Are LDTs and How Are They Regulated?
December 30th 2015

What Are LDTs and How Are They Regulated?

Introduction
December 30th 2015

Introduction

Site Logo
December 30th 2015

Physicians Discover Palbociclib Effective in Cancers Beyond Those of the Breast

Surabhi Dangi-Garimella, PhD
A literature review by researchers at the Abramson Cancer Center has identified a potential use of the cell cycle inhibitor palbociclib in a variety of cancers.
Site Logo
December 30th 2015

Most-Read Articles From AJMC's Conference Coverage in 2015

Surabhi Dangi-Garimella, PhD
Studies that provided updates on new drug trials, sessions on value-based care, and the cost of healthcare, were most popular among readers of The American Journal of Managed Care.
Site Logo
December 29th 2015

Using Technology to Bring Palliative Care to the Patient's Doorstep

Surabhi Dangi-Garimella, PhD
After having launched a palliative care program in 2014, Cambia Health Solutions is now looking for ways to improve patient access to these tools that can improve a patient's quality of life.
Site Logo
December 29th 2015

Cost, Value of Cancer Drugs Take Center Stage in Current Issue of AJMC's Evidence-Based Oncology

One of the biggest stories of 2015 has been the cost of cancer drugs, which create vexing questions for payers and policymakers, as well as doctors and families. The tough choices being made today are the theme of the latest special issue of Evidence-Based Oncology, a publication of The American Journal of Managed Care.
Site Logo
December 28th 2015

Improving Cancer Trial Participation via Web-Based Interventions

Surabhi Dangi-Garimella, PhD
Patient awareness and educational support can improve their attitude as well as prepare them to make better informed decisions on clinical trial participation, a new study has found.
Site Logo
December 28th 2015

Report: Shkreli Arrest Prompts Cancer Center to Stop Trial

Mary K. Caffrey
Moffitt Cancer Center said there's nothing wrong with the drug, but a spokesman said the trial is halted for now pending the outcome of the investigation.
Site Logo
December 28th 2015

Cancer's Toll Beyond the Disease: Medical Costs and Productivity

Surabhi Dangi-Garimella, PhD
A new study published by the American Cancer Society found that younger colorectal cancer survivors end up spending over $8500 annually in medical expenses and they also experience significantly greater loss of productivity compared with individuals without cancer.
This Week in Managed Care: December 26, 2015
December 26th 2015

This Week in Managed Care: December 26, 2015

This week The American Journal of Managed Care offers a special episode of highlights from the American Society of Hematology's annual meeting, including sessions on newly approved treatments, how the move to pay-for-performance affects hematologists, and the increasing role of patient-reported outcomes.
Site Logo
December 25th 2015

Most-Viewed Videos from AJMC for the Year 2015

Surabhi Dangi-Garimella, PhD
Top 10 videos from The American Journal of Managed Care's Summit and Insight programs.
Site Logo
December 23rd 2015

Rivaroxaban Safe and Effective in Cancer Patients With Thrombosis

Laura Joszt, MA
Although rivaroxaban was approved by the FDA in 2012, there has remained a knowledge gap about how it works with cancer patients. A recent study found that the therapy is safe and effective when used among patients with cancer.
Site Logo
December 22nd 2015

OB-GYN Groups Say Insurers' Genetic Testing Rules Limit Access to Care

Mary K. Caffrey
The statement from the obstetricians and gynecologists said that there aren't enough certified genetic counselors to meet demand. In a statement, the groups said this will limit access to care if patients must wait for assistance before ordering tests.
<1
...
115116117118119120121122123
...
188>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo